Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease
Clinical trial NCT03623321 · COMPLETED
Trial details
- NCT number
- NCT03623321
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-17
- Primary completion
- 2023-05-05
- Enrollment
- 595
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.